| 期刊全稱 | Biomarkers in Cancer Therapy | | 期刊簡稱 | Liquid Biopsy Comes | | 影響因子2023 | Hideaki Shimada | | 視頻video | http://file.papertrans.cn/188/187807/187807.mp4 | | 發(fā)行地址 | Casts new light on liquid biopsy biomarkers for cancer screening.Equips readers to treat molecular targeting therapy positively.Maximizes reader insights into cancer screening and early diagnosis | | 圖書封面 |  | | 影響因子 | .This book sheds new light on research into liquid biopsy biomarkers for cancer screening. The chapters in the first half address exosomes, circulating cell-free DNA and autoantibodies, and main solid cancers, along with companion biomarkers – all of which serve as the basis for exploring key research questions for future clinical trials in the book’s second half..The study of biomarkers has evolved rapidly thanks to advances in precision medicine. While conventional cancer biomarker research is focused on proteomics or gene analysis of resected tissue, diagnostic markers have since become significant in terms of gauging the effectiveness of molecularly targeted drugs or the likelihood of a favorable prognosis. In addition, conventional treatment strategy, which draws on archives of resected tissue samples, is now gradually being replaced by monitoring with the use of liquid biopsy, which is poised to become the new mainstream in molecular targeting therapy...The contributing authors discuss in detail biomarkers, molecular targets for treatment, monitoring markers to evaluate treatment responses, prognostic markers, and screening and early diagnosis. Accordingly, this excellent col | | Pindex | Book 2019 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-11 14:56
發(fā)表于 2025-3-21 18:59:37
